? Class 4 Medicines Defect Information: Aspar Pharmaceuticals Limited, Ibuprofen 200mg and 400mg tablets

 

Aspar Pharmaceuticals Limited has informed the MHRA that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.

 

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

 

This circular is being shared under the Open Government Copyright licence. Whilst we will publish alerts relevant to pharmacists, pharmacy technicians and pharmacy teams we recommend you also keep an eye on the SHOW website.

 

Published by

PIP editor

A pharmacist led training provider.

Leave a Reply

Your email address will not be published.